Drugs Approved for Soft Tissue Sarcoma - National Cancer Institute

Drugs Approved for Soft Tissue Sarcoma - National Cancer Institute

Drugs Approved for Soft Tissue Sarcoma

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.

ON THIS PAGE

• Drugs Approved for Soft Tissue Sarcoma
• Drug Combinations Used in Soft Tissue Sarcoma

Drugs Approved for Soft Tissue Sarcoma

• Cosmegen (Dactinomycin)
• Dactinomycin
• Doxorubicin Hydrochloride
• Eribulin Mesylate
• Gleevec (Imatinib Mesylate)
• Halaven (Eribulin Mesylate)
• Imatinib Mesylate
• Lartruvo (Olaratumab)
• Olaratumab
• Pazopanib Hydrochloride
• Trabectedin
• Votrient (Pazopanib Hydrochloride)
• Yondelis (Trabectedin)

Drug Combinations Used in Soft Tissue Sarcoma

• VAC

Related Resources

• Soft Tissue Sarcoma—Patient Version
• Chemotherapy and You: Support for People With Cancer